Impact of off-pump coronary artery surgery on myocardial performance and beta-adrenoceptor function

N Eldrup1, N H Rasmussen, S Yndgaard

  • 1Department of Anesthesiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

Insights

Off-pump coronary artery bypass surgery causes temporary hemodynamic changes in major coronary arteries. Cardiovascular beta-adrenoceptor function remains stable, unlike with cardiopulmonary bypass surgery.

Area of Science:

  • Cardiovascular Anesthesia
  • Cardiac Surgery
  • Hemodynamics

Background:

  • Off-pump coronary artery bypass (OPCAB) surgery is an alternative to traditional bypass surgery.
  • Understanding hemodynamic changes and beta-adrenoceptor function during OPCAB is crucial for patient management.

Purpose of the Study:

  • To assess hemodynamic alterations during OPCAB surgery on the left anterior descending, circumflex, and right coronary arteries.
  • To evaluate cardiovascular beta-adrenoceptor function before and after OPCAB surgery.

Main Methods:

  • Prospective study in a university cardiothoracic anesthesia department.
  • Twenty patients undergoing OPCAB surgery using the Octopus 2 stabilizer system.
  • Isoproterenol administration to monitor beta-receptor function pre- and post-surgery.

Main Results:

  • Temporary decreases in stroke volume and cardiac index were observed during revascularization of all three major coronary arteries.
  • Hemodynamic variables returned to baseline within 5 minutes after releasing the heart.
  • No significant changes in hemodynamic responses to isoproterenol were detected post-surgery.

Conclusions:

  • Hemodynamic changes during OPCAB surgery on major coronary arteries are transient and similar.
  • Cardiovascular beta-adrenoceptor function is not impaired after OPCAB surgery.
  • This contrasts with impaired beta-adrenoceptor function observed after surgery with cardiopulmonary bypass.
Abstract

Related Concept Videos

Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...